GlassScriptPhysician profile
Tara D Winchester
NPI 1528034659
$4,816.44
in general payments reported to CMS, 2019-2025
42 companies · $895 in 2025
The $895 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $176 · 2021: $438 · 2022: $1,157 · 2023: $927 · 2024: $831 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,652.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $723.94 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $516.84 | 2021-2025 | |
| Exeltis, USA INC. | $495.94 | 2020-2025 | Slynd |
| Gynesonics, INC. | $329.15 | 2021-2022 | |
| Sage Therapeutics, LLC | $298.25 | 2022-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $230.26 | 2021-2024 | Twirla |
| Sumitomo Pharma America, INC. | $217.61 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $199.05 | 2019-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $170.96 | 2021-2022 | |
| Therapeuticsmd, INC. | $170.05 | 2019-2022 | |
| Novo Nordisk INC | $140.36 | 2019-2021 | |
| Millicent US INC | $122.78 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Shield Therapeutics INC | $105.11 | 2023-2025 | Accrufer |
| Aspira Women'S Health INC | $95.53 | 2022-2024 | Ova1 |
| Pfizer INC. | $84.86 | 2021-2024 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Winchester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.